| (Values in U.S. Thousands) | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 |
| Sales | 4,050 | 150 | 510 | 0 | 0 |
| Sales Growth | +2,599.98% | -70.59% | unch | unch | unch |
| Net Income | -12,410 | -26,450 | -95,260 | 4,650 | -40 |
| Net Income Growth | +53.08% | +72.23% | -2,148.60% | +11,725.29% | unch |
Foxo Technologies Inc
(FOXO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
FOXO Technologies Inc. is a technology platform company whose products and services seek to address long-standing, core problems within the life insurance industry through epigenetic longevity science. FOXO Technologies Inc., formerly known as Delwinds Insurance Acquisition Corp., is based in MINNEAPOLIS.
Fiscal Year End Date: 12/31